713 East Minnehaha Avenue
InSitu Biologics develops and manufactures implantable timed release products composed of our proprietary tunable, bio-polymeric hydrogel, Matrix. The physical properties allow us to create less viscous products for small spaces and more viscous products that prevent migration. We are currently pursuing applications for delivery in soft and bone tissue(s).
Co-Founder: Stefano M. Sinicropi, MD
Managing Director: Greg Simpson
Please click here for InSitu Biologics' technology.